Skip to main content
FinSpry Logo
FinSpry
TCRT logo
TCRT
(NASDAQ)
Alaunos Therapeutics, Inc.
$2.46-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Alaunos Therapeutics (TCRT) Stock Price & Financial Analysis

Alaunos Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.46 - $2.64
52-Week High$6.20
52-Week Low$1.67
Open$2.53
Volume25.64K
Average Volume (3M)12.66K
Market Cap4.79M
Shares Outstanding1.95M
Price to Sales (P/S)962.49
Price to Book (P/B)2.24
EV/EBITDA-0.81
Revenue (TTM)5.00K
Net Income (TTM)-4.18M
Free Cash Flow (TTM)-3.00M
EPS (TTM)$-2.25
Profit Margin-83520.00%
Operating Margin-84500.00%
Return on Equity (ROE)-193.96%
Debt to Equity0.00
50-Day MA$2.96
200-Day MA$2.90
52-Week Change-7.72%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Alaunos Therapeutics

What is the current stock price for TCRT?

As of the latest trading session, TCRT stock trades at $2.46. The 52-week range is $1.67–$6.20, with a day range of $2.46–$2.64.

What is the P/E ratio for TCRT?

The P/E ratio (Price-to-Earnings) for TCRT is shown in the Key Statistics section. This valuation metric helps compare Alaunos Therapeutics, Inc. to industry peers.

Does TCRT pay dividends?

Alaunos Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TCRT?

Analyst ratings and recommendations for TCRT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of TCRT?

Alaunos Therapeutics's market capitalization is $4.8M, classifying it as a micro-cap company. Alaunos Therapeutics operates in the Healthcare sector within the Biotechnology industry.